Stifel Financial Corp reduced its position in HCA Healthcare Inc (NYSE:HCA) by 3.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,819 shares of the company’s stock after selling 610 shares during the period. Stifel Financial Corp’s holdings in HCA Healthcare were worth $2,216,000 at the end of the most recent quarter.
A number of other hedge funds have also recently modified their holdings of the business. Chicago Equity Partners LLC increased its holdings in shares of HCA Healthcare by 4.6% during the 4th quarter. Chicago Equity Partners LLC now owns 1,841 shares of the company’s stock valued at $229,000 after acquiring an additional 81 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in HCA Healthcare by 11.2% during the 4th quarter. Quadrant Capital Group LLC now owns 847 shares of the company’s stock valued at $93,000 after purchasing an additional 85 shares during the period. Advisor Partners LLC boosted its stake in HCA Healthcare by 2.3% during the 4th quarter. Advisor Partners LLC now owns 5,079 shares of the company’s stock valued at $632,000 after purchasing an additional 113 shares during the period. Commonwealth Bank of Australia boosted its stake in HCA Healthcare by 4.6% during the 4th quarter. Commonwealth Bank of Australia now owns 2,783 shares of the company’s stock valued at $344,000 after purchasing an additional 122 shares during the period. Finally, Whitener Capital Management Inc. boosted its stake in HCA Healthcare by 50.0% during the 4th quarter. Whitener Capital Management Inc. now owns 474 shares of the company’s stock valued at $58,000 after purchasing an additional 158 shares during the period. 71.37% of the stock is currently owned by institutional investors.
Several analysts recently weighed in on HCA shares. Zacks Investment Research restated a “buy” rating and set a $134.00 target price on shares of HCA Healthcare in a research note on Monday, December 31st. Jefferies Financial Group set a $158.00 target price on HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday. SunTrust Banks raised their price objective on HCA Healthcare to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, January 30th. Deutsche Bank started coverage on HCA Healthcare in a research report on Thursday, January 3rd. They issued a “buy” rating and a $140.00 price objective for the company. Finally, ValuEngine downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, March 6th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and seventeen have given a buy rating to the company’s stock. HCA Healthcare presently has a consensus rating of “Buy” and an average target price of $148.19.
HCA stock traded up $3.23 during midday trading on Friday, reaching $115.24. 3,832,198 shares of the company’s stock traded hands, compared to its average volume of 1,821,018. The stock has a market capitalization of $39.59 billion, a price-to-earnings ratio of 11.80, a P/E/G ratio of 0.96 and a beta of 0.78. HCA Healthcare Inc has a 1-year low of $93.03 and a 1-year high of $147.42.
HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 29th. The company reported $2.99 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.59 by $0.40. HCA Healthcare had a negative return on equity of 91.25% and a net margin of 8.11%. The company had revenue of $12.27 billion during the quarter, compared to analysts’ expectations of $12.10 billion. During the same period last year, the firm earned $2.12 EPS. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. As a group, equities research analysts forecast that HCA Healthcare Inc will post 10.01 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 29th. Investors of record on Friday, March 1st were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, February 28th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.35. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.39%. HCA Healthcare’s payout ratio is 16.38%.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.baseballdailydigest.com/news/2019/04/21/hca-healthcare-inc-hca-shares-sold-by-stifel-financial-corp.html.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Article: Trading signals using Bollinger bands
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.